DIMENSIONAL FUND ADVISORS LP
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 354204
AUSTIN, TX
Position in VRDN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$10,362,162
-$6,927,921 QoQ
Shares Held
529,763
-4.6% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 87%
Shared 10%
None 3%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. VRDN ranks #72 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in VRDN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,362,162 | 529,763 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $17,290,083 | 555,594 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,784,805 | 638,777 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,790,056 | 485,698 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $1,072,062 | 55,924 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,441,070 | 327,080 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,399,615 | 107,580 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $176,325 | 10,070 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $219,324 | 10,070 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $154,473 | 10,070 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $239,565 | 10,070 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $277,957 | 10,926 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $332,935 | 11,398 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $233,772 | 11,398 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $131,874 | 11,398 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||